Atlas Trials

Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia

Clinical trial NCT02825212 · COMPLETED

Trial details

NCT number
NCT02825212
Sponsor
Icahn School of Medicine at Mount Sinai
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hepatitis CCryoglobulinemia
Start date
2016-02-01
Primary completion
2019-07-19
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.